Literature DB >> 15352426

Outcome of patients with systemic lupus erythematosus in intensive care unit.

A H Alzeer1, A Al-Arfaj, S J Basha, S Alballa, J Al-Wakeel, H Al-Arfaj, S Al-Sugair, S Al-Mugeiren, M Al-Shamairi, E A Bamgboye.   

Abstract

The objective of the study was to identify the causes, outcome and prognosis of severe illness in patients with systemic lupus erythematosus (SLE) requiring intensive care unit (ICU) care in a University Hospital over a five-year period. The design was a cohort study. Forty-eight SLE patients requiring ICU management over a five-year period (January 1997-December 2001) were studied prospectively. Of 48 patients, 14 (29.2%) died, predominantly with multiorgan dysfunction syndrome (MODS). Patients whose APACHE II score was equal to or greater than 20 had higher mortality than those with APACHE score below 20 (60 versus 7.1%; and P < 0.01). All the 18 patients whose health status rated as 'good' survived, while 46.7% of 30 patients whose health rated as 'poor' died (P < 0.01). Patients who had thrombocytopenia associated with sepsis and/or disseminated intravascular coagulopathy (DIC) had the highest mortality (75%, five-year survival). In conclusion, SLE patients admitted to the ICU had a lower mortality rate than some of the previous reports. Patients with SLE with high APACHE score, > or =20, poor health status, thrombocytopenia and multiorgan dysfunction syndrome had poor prognosis in the ICU.

Entities:  

Mesh:

Year:  2004        PMID: 15352426     DOI: 10.1191/0961203304lu1057oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  8 in total

1.  Outcome of patients with connective tissue disease requiring intensive care for respiratory failure.

Authors:  Jinwoo Lee; Jae-Joon Yim; Seok-Chul Yang; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Eun Young Lee; Eun Bong Lee; Yeong Wook Song; Sang-Min Lee
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

Review 2.  [Rheumatic patients in the intensive care unit].

Authors:  P Lehmann; T Brünnler; B Salzberger; M Fleck
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-02       Impact factor: 0.840

3.  Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit.

Authors:  Alimohammad Fatemi; Somayeh Shamsaee; Ahmad Raeisi; Zahra Sayedbonakdar; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

4.  [Outcome of intensive medical care for inflammatory rheumatic diseases].

Authors:  L A Rütter; S Rütter; M Winkler; G Keyßer
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

5.  Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis.

Authors:  Santiago Bernal-Macías; Benjamín Reyes-Beltrán; Nicolás Molano-González; Daniel Augusto Vega; Claudia Bichernall; Luis Aurelio Díaz; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Lupus Sci Med       Date:  2015-12-01

6.  Factors Associated with Mortality in Patients with Autoimmune Diseases Admitted to the Intensive Care Unit in Bogota, Colombia.

Authors:  Jorge Armando Carrizosa; Jorge Aponte; Diego Cartagena; Ricard Cervera; Maria Teresa Ospina; Alexander Sanchez
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

7.  Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran.

Authors:  Mojgan Arjmand; Reza Shahriarirad; Saeedeh Shenavandeh; Mohammad Javad Fallahi
Journal:  Clin Rheumatol       Date:  2022-08-15       Impact factor: 3.650

8.  Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection.

Authors:  Meggan Mackay; Michaela Oswald; Jorge Sanchez-Guerrero; Juan Lichauco; Cynthia Aranow; Sean Kotkin; Ilya Korsunsky; Peter K Gregersen; Betty Diamond
Journal:  Lupus Sci Med       Date:  2016-11-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.